Korea's pharmaceutical pricing system

The government intends not to cut the insurance price of an original drug if a generic product is not launched despite its listing in the eligible health insurance. However, any patent trial to confirm the scope of a patent right will not give any impact to the price readjustment.

In a meeting with representatives from the pharmaceutical industry on November 5, the Ministry of Health, Welfar...